Connect Biopharma Holdings
CNTB
29 hedge funds and large institutions have $87.4M invested in Connect Biopharma Holdings in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 8 closing their positions.
113% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 8
45% more funds holding
Funds holding: 20 → 29 (+9)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
4.22% less ownership
Funds ownership: 33.73% → 29.51% (-4.2%)
81% less capital invested
Capital invested by funds: $467M → $87.4M (-$380M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $88K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$3.09M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.91M |
| 4 |
ACM
Altium Capital Management
New York
|
+$1.95M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$50.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$27.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.6M |
| 4 |
BlackRock
New York
|
-$3.4M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.33M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $15K | +$21.8K | +1,965 | +197% |
|
27
JP Morgan Chase
New York
| $15K | +$31.9K | +2,868 | New |
|
28
UBS Group
Zurich,
Switzerland
| $4K | +$3.85K | +346 | +80% |
|
|
BC
29
Boxer Capital
San Diego,
California
| – | -$50.4M | -2,081,323 | Closed |
|
|
30
Wellington Management Group
Boston,
Massachusetts
| – | -$27.4M | -1,145,177 | Closed |
|
|
OWP
31
Old Well Partners
Charlotte,
North Carolina
| – | -$2.97M | -122,431 | Closed |
|
|
ECM
32
ExodusPoint Capital Management
New York
| – | -$470K | -19,400 | Closed |
|
33
State Street
Boston,
Massachusetts
| – | -$420K | -17,527 | Closed |
|
|
PL
34
Parkwood LLC
Cleveland,
Ohio
| – | -$375K | -15,469 | Closed |
|
|
VIA
35
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$263K | -10,851 | Closed |
|
36
Daiwa Securities Group
Tokyo,
Japan
| – | -$147K | -6,069 | Closed |
|
37
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | +$67 | +6 | New |
|
CNTB Hedge Fund Activity: Q4 2021 in Review
29 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q4 2021, worth a combined $87.4M — down 81% from $467M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CNTB positions and 8 closed out — a net gain of 9 holders — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $13.9M. The largest seller was Boxer Capital, exiting entirely with an estimated $50.4M sold.
- 29 institutional investors held Connect Biopharma Holdings (CNTB) as of Q4 2021, up from 20 in Q3 2021.
- Funds reported $87.4M of Connect Biopharma Holdings stock for Q4 2021, down 81% quarter-over-quarter.
- 17 funds opened new Connect Biopharma Holdings positions in Q4 2021 and 8 closed out, a net change of +9 holders.
- The largest Connect Biopharma Holdings buyer in Q4 2021 was Adage Capital Partners, an estimated $13.9M added.
- The largest Connect Biopharma Holdings seller in Q4 2021 was Boxer Capital, an estimated $50.4M sold.
Based on aggregated 13F filings for Q4 2021.